Clinical Trial Update: Safety and Efficacy Study of a Fluoroquinolone to Treat Complicated Skin Infections [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy study of a fluoroquinolone for complicated skin infections completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Skin Infections
• Skin and Soft Tissue Infections
• Staphylococcus Aureus Infections

Drugs mentioned

• Delafloxacin (delafloxacin)

Snippet

Sponsor: Melinta Therapeutics, Inc. | Conditions: Skin Structure Infections, Bacterial Skin Diseases | Phase 2 | Status: COMPLETED | Results posted: 2010-02-03